Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety update regarding ELEVIDYS (dela ...

Our finding that the spliceosome deposits a multi‐protein complex 20‐‐24 nt upstream of exon–exon junctions on multiple mRNAs was unexpected. Not only is there is no consensus sequence in this region, ...

Ten Indian American scientists were honored for their outstanding contributions in cancer research by the (SAASCR).

The intron lariat remained bound in the spliceosome, whereas the ligated exon was already dissocd. Step II splicing factors Prp17 and Prp18, along with Cwc21 and Cwc22 that stabilize the 5' exon ...